T he development of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) is the most important complication after SAH and has a severe impact on outcome for the patients. It accounts for up to 30% of new neurological deficits after the initial hemorrhage. 20 ,34 Yet, to date, the occurrence of DCI still cannot be predicted reliably for the individual patient. Furthermore, the importance of angiographic cerebral vasospasm (CVS) for the occurrence of DCI has recently been critically discussed. 20, 29, 42 One of the standard methods to assess the risk of the occurrence of DCI and CVS is the scale proposed by Fisher et al. 9 The scale uses 4 grades to describe the amount of subarachnoid blood evident on CT: 1, no visible subarachnoid blood; 2, only a thin layer of subarachnoid blood or diffuse SAH; 3, a localized clot or a thick layer of subabbreviations ACoA = anterior communicating artery; CVS = cerebral vasospasm; DCI = delayed cerebral ischemia; ICA = internal carotid artery; ICH = intracerebral hematoma; ICP = intracranial pressure; IVH = intraventricular hemorrhage; MCA = middle cerebral artery; mFS = modified Fisher Scale; oFS = original Fisher Scale; PCoA = posterior communicating artery; SAH = subarachnoid hemorrhage; TCD = transcranial Doppler ultrasound; WFNS = World Federation of Neurosurgical Societies. The authors compared the original and modified Fisher Scales with respect to the occurrence of DCI. The modified Fisher Scale (mFS) was superior to the original Fisher Scale (oFS) in predicting DCI. Furthermore, they suggest a new classification based on the mFS, which demonstrates the impact of additional ICH on the occurrence of DCI.
arachnoid blood; and 4, intraventricular or intracerebral blood with no subarachnoid blood or only diffuse or a thin layer of subarachnoid blood. The major weakness of the scale is that most of the patients are grouped into Grade 3, which is associated with the highest risk of developing CVS. Many corrections of the original Fisher Scale (oFS) have been suggested, but only the modified Fisher Scale (mFS) 5, 11 has been widely accepted today; most other scales are too complicated or have other flaws.
The influence of an additional intracerebral hematoma (ICH) on the occurrence of CVS and DCI is underrepresented in both the oFS and mFS. We therefore retrospectively reviewed a large number of cases involving patients treated at our center to assess whether additional ICH might represent a risk factor for the occurrence of DCI.
Methods study Design and inclusion and exclusion criteria
Data pertaining to all patients treated at our center and suffering from aneurysmal SAH were entered into a prospectively collected database. For this study, we retrospectively reviewed cases involving patients treated between 2006 and 2011. Patients' charts and imaging data were reviewed, and the presence of ICH was assessed and stratified as described below. Imaging was reviewed in a blinded fashion. The study was approved by the local scientific and ethics review board.
Exclusion criteria were 1) patients with SAH due to other reasons or without aneurysms, 2) death or transfer to another hospital within 10 days after onset of SAH without the development of DCI, and 3) missing data.
end Point
Our primary end point for this study was the occurrence of DCI as detected by imaging. CT or MRI was performed in all cases 24-48 hours after aneurysm occlusion and before discharge. DCI was defined as any new ischemic lesion on the CT or MRI before discharge compared with the imaging after aneurysm occlusion. Thus, periprocedural ischemic lesions due to securing of the aneurysm were ruled out.
Classification of SAH and ICH
Assessment of the CT scans was performed with the rater blinded to the occurrence of DCI. Additional ICH was defined as the presence of any localized parenchymal hematoma additional to the SAH. According to the location of the ICH, the patients were categorized into 3 groups for analysis ( Fig. 1 ): 1) patients with hematomas located within the frontal lobe, 2) patients with hematomas located within the temporal lobe, and 3) patients with perisylvian hematomas. For the location of the hematoma, the imaging data were reviewed as well as operative reports, when available.
The patients were assigned oFS and mFS grades according to the blood distribution on the initial CT. For the mFS, we used the presence of any intraventricular blood rather than biventricular hematoma as suggested by Frontera et al. 11 Last, we subdivided the mFS according to the presence (+) or absence (−) of ICH at each grade.
Patient Management
After diagnosis of SAH, a digital subtraction 4-vesselangiogram was routinely performed. Hemodynamic target values included a cerebral perfusion pressure greater than 60 mm Hg and the correction of hyponatremia and hypovolemia.
Aneurysms were treated by clipping or coiling according to the decision of an interdisciplinary neurovascular team based on the aneurysm's characteristics and the clinical condition of the patient. Hydrocephalus was treated by placement of an external ventricular drain. Early aneurysm occlusion (within 24 to 48 hours) was striven for in all cases unless the patient was hemodynamically unstable or moribund. After the aneurysm was secured, all patients were treated in the neurosurgical intensive care unit. All patients received nimodipine from the day of admission, either orally (6 × 60 mg/day) or intravenously (2 mg/hour). Screening for CVS included daily clinical examination and transcranial Doppler ultrasound (TCD) measurements. If CVS was suspected clinically or on the basis of TCD, the patient underwent additional imaging studies, such as CT or MR angiography (sometimes including perfusion studies) or digital subtraction angiography.
In cases of confirmed CVS, we treated the patients with induced hypertension (mean arterial pressure > 110 mm Hg). Endovascular treatment options for severe CVS, such as intraarterial administration of nimodipine and/or balloon dilation, were applied in selected patients.
statistical analysis
First, we performed a univariate analysis for the occurrence of DCI and the presence of ICH. We included various other typical risk factors: patients' sex and age (mean), WFNS (World Federation of Neurosurgical Societies) grade on admission, the site and size of the ruptured aneurysm, treatment of the ruptured aneurysm, and the amount of subarachnoid blood as defined according to the oFS and mFS. The chi-square-test, Fisher's exact test, and Mann-Whitney U-test were used as appropriate.
Second, we performed a multivariate analysis (logistic regression, stepwise forward, Wald model) assessing the different SAH rating scales. Any variables that were significant on univariate analysis, or variables considered clinically meaningful, were adjusted for in the multivariate analysis. Each CT rating scale was analyzed separately in this model. A p value < 0.05 was considered statistically significant. All statistical analyses were performed using standard commercially available software (IBM SPSS Statistics, version 21).
results
Between 2006 and 2011, a total of 579 patients with aneurysmal SAH were treated at our center. After exclusion of 23 patients due to missing data and 52 patients who died or were transferred before DCI would be expected to develop, 504 patients were included in this study (66.7% of the patients were female, Table 1 ). An additional hematoma was found in 123 patients (24.4%). The hematoma location was frontal in 72 patients (14.3%), temporal in 24 patients (4.8%) and around the sylvian fissure in 27 patients (5.4%).
There was no significant difference in the patients' sex, their mean age, or size of the ruptured aneurysm between the groups with and without ICH ( Table 1) . Additional ICH was, however, more frequent in patients with higher WFNS grades and was most frequent in patients with aneurysms of the middle cerebral artery (MCA).
In all patients, the aneurysm was located most often at the anterior communicating artery (ACoA) complex (198 patients, 39. (Table 1) .
Overall, most aneurysms in this study were treated endovascularly (314, 62.3%) but in patients with additional ICH, the rate of surgical treatment significantly increased (60 [48.8%] of 123 patients vs 108 [28.3%] of 381 patients without ICH, p < 0.001). In 12 patients, the aneurysm was not occluded (because of poor admission status and/or because occlusion was technically not feasible) while in 10 patients, a combined microsurgical and endovascular approach was used.
Occurrence of Delayed Ischemic Deficits
Overall, DCI was detected in 183 patients (36.3%, the location of ICH, we found that perisylvian hematomas were most often associated with DCI (51.9%), followed by temporal (50.0%) and frontal hematomas (45.8%, p = 0.019).
Furthermore, DCI occurred more frequently in patients with higher WFNS grades (p < 0.001) and in female patients (p = 0.018). In patients with DCI, the ruptured aneurysm was most often located at the MCA (48.4% of all MCA aneurysms, p = 0.024). There was no significant difference in the frequency of DCI according to the patients' mean age (p = 0.510), the mean aneurysm size (p = 0.730), or aneurysm treatment (p = 0.101). In both scales, the risk of developing DCI varied significantly.
We then tested whether the additional rating of ICH in the mFS results in a further improvement in the prediction of DCI. As shown in Table 3 , patients with ICH in this classification of the mFS in general have a higher risk of developing ICH than the corresponding patients without ICH. Furthermore, there is a rather continuous increase in the OR for development of DCI rising from Grade 0 to 4+.
Finally, we tested the predictive value of the different CT grading scales for the occurrence of DCI in a multivariate model and adjusted for the patients' age, sex, WFNS grade at admission, and aneurysm location (Table  3) . After adjustment for these factors, the oFS no longer was an independent predictor of the occurrence of DCI, while the mFS just barely retained its significance (p = 0.046). In contrast, the mFS including ICH grading was a highly significant independent predictor (p = 0.018), and patients with a Grade 4+ had an almost 10-fold increased risk of developing DCI compared with patients with a Grade 0 SAH. Again, patients with ICH almost always had a higher risk of developing DCI than the patients without ICH in the same grade.
Discussion
The classification of the amount and distribution of subarachnoid blood originally suggested by Fisher et al. has been widely accepted in the neurosurgical community for assessing the risk of the occurrence of vasospasm. 9 This original Fisher Scale (oFS) was revised in 2001 and 2006 and since then, the modified Fisher Scale (mFS) has been used routinely. 5, 11 Nevertheless, the presence and effect of additional ICHs is underrepresented in both classifications. In this study, we demonstrate that additional ICH may represent an important risk factor for the occurrence of DCI.
We chose the end point "occurrence of DCI" rather than "CVS" for various reasons. First, it seems more reliable to determine the presence of DCI based on identification of any new ischemic lesions, after ruling out procedure-related infarctions due to securing of the aneurysm, as this method relies on objective imaging data. Second, the definition of CVS is controversial and its detection is even more complicated. 29, 34 As the neurological status of many SAH patients cannot be assessed reliably due to a decreased level of consciousness, clinical deterioration may easily be missed as a sign of CVS. This is especially true in patients with additional ICH, whose status is often poor at admission. 34 Since the introduction of the original scale by Fisher et al., various modifications have been suggested to improve the predictability of DCI and the use of the scale in daily clinical practice. 5, 10, 11, 14, 16, 19, 23, 25, 27, 28, 32, 37 Yet, to date the oFS and mFS are still most widely used despite their weaknesses. The main flaws of the oFS are 1) its nonlinear character, with a decrease in the risk of vasospasm from Grade 3 to Grade 4; 2) its moderate interobserver reliability; 38 and 3) the manner in which intraventricular hemorrhage (IVH) and ICH are handled. On the other hand, most new scales are too complex for daily use or are focused on the presence of IVH, as the mFS. 11, 18, 19, 31, 32, 35, 38, 40, 41 There are some additional problems with the mFS as well. First, it has been developed and tested only in patients after surgical aneurysm repair. Endovascularly treated patients, who are in the majority today in most centers, were not considered in the development of the mFS. 5, 11 Furthermore, the developers of the mFS focused on the impact of IVH on the development of "symptomatic vasospasm." We think that the definition of "symptomatic vasospasm" as used then might no longer be accurate, as the concept of DCI has shifted with the impact of angiographic vasospasm diminishing. 20, 29, 34, 42 As an objective outcome parameter, DCI seems more suitable than "clinical vasospasm," which was often used in older studies and defined by clinical deterioration otherwise unexplained but which did not have to lead to delayed ischemia.
Whereas Claassen et al. 5 originally suggested classifying IVH as positive in patients with hemorrhage in both lateral ventricles only, Frontera et al. 11 rated IVH positive if there was blood in any ventricle. This created some uncertainty regarding the definition of IVH in the mFS, as large unilateral IVH could be regarded as "no IVH" using the definition of Claassen et al.
In the present study, we demonstrate that the mFS not only is valid for endovascularly treated patients but also remains valid with the more modern end point, "occurrence of DCI."
Although the impact of ICH on treatment and outcome of SAH has been studied often, 1, 4, 7, 12, 13, 15, 24, [26] [27] [28] 33, 39 data on the prediction of DCI due to ICH are very limited. 12 The presence of ICH was not assessed in detail in the mFS. Crobeddu et al. 6 found an association of ICH with the development of DCI on the univariate analysis, but it was not significant in the multivariate analysis.
As the occurrence of DCI is thought to be correlated with the amount of subarachnoid blood and its degradation products, 2, 3, 5, 16, 17, 21, 22 it seems reasonable that patients with additional ICH and hence more intracranial blood would be at a higher risk of developing DCI. One important difference in patients with isolated ICH, in whom DCI almost never occurs, might be that due to the underlying aneurysmal SAH, there usually is a readily accessible connection of the hematoma to the subarachnoid space. Thus, degradation products might increase not only the local risk of DCI but also the general risk of DCI, by an increased washout of degradation products into the subarachnoid space. As it was shown earlier that the odds of vasospasm decreased with an increase of the clearance rate of subarachnoid blood and the initial clot volume, 30 the reverse mechanism seems likely in the presence of ICH.
This hypothesis emphasizes the role of hematomas located within the sylvian fissure and thus within the subarachnoid space directly. In the present study, perisylvian hematomas showed the highest risk of DCI (occurring in 51.9% of perisylvian hematomas), while frontal hematomas had the lowest risk of DCI (45.8%, Table 2 ). Additional ICH was most frequent in patients with MCA aneurysms, which usually result in perisylvian or temporal hematomas. Although we did not assess hematoma volume in this study, hematomas caused by MCA aneurysms are often larger than those seen in ruptured ACoA aneurysms. One other study found an increased risk of CVS in sylvian fissure hematomas compared with subpial hematomas due to ruptured MCA aneurysms. 33 Another mechanism resulting in a higher rate of DCI in patients with additional ICH might be a more severe early brain injury. 36 The additional volume of the hematoma itself might easily explain a higher initial peak and longer sustained increase in intracranial pressure (ICP) than in patients without ICH. Elevated ICP may be correlated with the extent of early brain injury, which may itself contribute severely to the occurrence of DCI.
As the adjusted mFS (the mFS including ICH) had the highest significance after adjustment for possible confounders in this study, the importance of additional ICH to predict DCI is underlined. Yet, again, we cannot distinguish whether this is due to the increased amount of blood or an increased early brain injury or both.
For a better assessment of the risk for the patient of the occurrence of DCI, an easy modification of the Fisher scale may be performed: the presence of ICH could be marked by "+" and the absence of ICH with "−", thus allowing better identification of high-risk patients.
limitations of the study
First, this study is retrospective, thus the typical limitations, such as selection bias, bias due to missing data, and lack of randomization, apply. To partly address the issue of selection bias, the rater was blinded to the occurrence of DCI when quantifying the CT scans. Furthermore, we did not consider hematoma size. Yet, for daily practice, it seems best to distinguish only between patients with and those without hematoma. If one were to consider hematoma size, the assessment would be a lot more complicated, and the scale would have to be more complex as well. As complex scales are often regarded as cumbersome, their use in daily practice is limited.
Last, there is an ongoing debate on the correct time point for grading the amount of subarachnoid blood. Due to the clearance of the brain, the blood is washed out soon after the hemorrhage. Therefore, various groups have suggested different time windows for the grading, which might have to be as early as within the first 24 hours. 8 In this study, we did not analyze the timing of the CT, which was used for grading. On the other hand, wash-out of localized hematomas usually takes longer than that of subarachnoid blood.
As this is a retrospective single-center study, these findings need prospective validation in independent cohorts before they can reliably applied in practice.
conclusions
In this study, we demonstrate that additional ICH increases the risk of DCI after SAH. Futhermore, we confirm for the first time that the mFS holds true in predicting DCI in endovasculary treated SAH patients. A simple modification of the mFS incorporates the additional risk of ICH and helps to improve the identification of patients with the highest risk of DCI. This risk seems to be greatest in cases of perisylvian hematomas, where the blood and its degradation products are located within the subarachnoid space in close proximity to major vessels. Whether the blood itself or a more severe early brain injury is the underlying mechanism for this increased risk of DCI remains unclear. Of course, for future validation, prospective studies are warranted. 
